ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
FTSE 100
8,768.01
0.41%
Dow Jones
44,546.08
-0.37%
Gold vs US Dollar
2,897.50
0.51%
Brent Oil
74.855
0.84%
Bitcoin
95,351.79
-0.81%
Pepperstone
Advertisement
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Traws Pharma Inc (TRAW)

  7. Traws Pharma Inc (TRAW) News

Traws Pharma (TRAW)

Traws Pharma Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:TRAW
DateTimeSourceHeadlineSymbolCompany
14/02/202521:22Edgar (US Regulatory)Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:TRAWTraws Pharma Inc
14/02/202518:18Edgar (US Regulatory)Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:TRAWTraws Pharma Inc
13/02/202518:07Edgar (US Regulatory)Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:TRAWTraws Pharma Inc
10/02/202521:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TRAWTraws Pharma Inc
08/02/202501:16Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:TRAWTraws Pharma Inc
07/02/202521:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TRAWTraws Pharma Inc
06/02/202521:15Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:TRAWTraws Pharma Inc
31/01/202521:30Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:TRAWTraws Pharma Inc
28/01/202500:02Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TRAWTraws Pharma Inc
28/01/202500:01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TRAWTraws Pharma Inc
28/01/202500:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TRAWTraws Pharma Inc
27/01/202521:15Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:TRAWTraws Pharma Inc
23/01/202512:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TRAWTraws Pharma Inc
23/01/202512:00PR Newswire (US)Traws Pharma Announces Completion of Phase I Studies with Tivoxavir Marboxil, a Single Dose Oral Investigational Drug for the Treatment and Prevention of H5N1 Bird FluNASDAQ:TRAWTraws Pharma Inc
23/01/202505:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:TRAWTraws Pharma Inc
15/01/202511:33Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:TRAWTraws Pharma Inc
10/01/202522:55PR Newswire (US)Expert Systems and Traws Pharma Report Breakthrough in H5N1Bird Flu Antiviral ProgramNASDAQ:TRAWTraws Pharma Inc
09/01/202502:28Edgar (US Regulatory)Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:TRAWTraws Pharma Inc
31/12/202422:23Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TRAWTraws Pharma Inc
31/12/202422:23Edgar (US Regulatory)Form 424B4 - Prospectus [Rule 424(b)(4)]NASDAQ:TRAWTraws Pharma Inc
30/12/202413:00PR Newswire (US)Traws Pharma, Inc. Announces Financing up to $72.6 Million from Leading Healthcare Institutional Investors to Advance Tivoxavir Marboxil Development for H5N1 Bird Flu to ApprovalNASDAQ:TRAWTraws Pharma Inc
23/12/202412:00PR Newswire (US)Traws Pharma Announces Progress in Developing Tivoxavir Marboxil for H5N1 Bird FluNASDAQ:TRAWTraws Pharma Inc
20/12/202422:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TRAWTraws Pharma Inc
22/11/202422:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TRAWTraws Pharma Inc
15/11/202421:06Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:TRAWTraws Pharma Inc
14/11/202422:10Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:TRAWTraws Pharma Inc
14/11/202421:40Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TRAWTraws Pharma Inc
01/11/202421:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TRAWTraws Pharma Inc
23/10/202421:00Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:TRAWTraws Pharma Inc
11/10/202412:46Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:TRAWTraws Pharma Inc
 Showing the most relevant articles for your search:NASDAQ:TRAW

Your Recent History

BIT
UV8B4H
UniCredit Bank
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2025 ADVFN PLC - All Rights Reserved

    Go Ad-Free

    Subscribe to Ad free and enjoy an ad-free experience

    No Ads

    Try Now

    Keep the Ads